Pharmaceutical composition for preventing or treating graft-versus-host disease comprising anti-CXCL2 or anti-CXCR2 monoclonal antibody

摘要

The present invention relates to a pharmaceutical composition comprising anti-CXCL2 or anti-CXCR2 monoclonal antibody for preventing or treating a graft-versus-host disease. The pharmaceutical composition according to the present invention prevents the graft-versus-host disease and enhances anti-tumor effect by relatively promoting movement of cancer cells by interfering with T-cells from accessing a target organ of the graft-versus-host disease.